GlassScriptPhysician profile
Christopher D Ewanowski
NPI 1780880476
$2,892.01
in general payments reported to CMS, 2019-2025
22 companies · $395 in 2025
The $395 reported for 2025 was less than what a typical Procedural Dermatology provider received nationally (typical 2025 total: $599).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $544 · 2020: $262 · 2021: $315 · 2022: $193 · 2023: $504 · 2024: $677 · 2025: $395.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,505 · Education: $72.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,505.28 |
| Education | $72.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $749.13 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Janssen Biotech, INC. | $561.48 | 2019-2025 | Tremfya |
| Novartis Pharmaceuticals Corporation | $321.38 | 2019-2025 | |
| Abbvie INC. | $303.56 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $151.40 | 2023-2025 | Winlevi, Absorica Ld |
| Galderma Laboratories, L.P. | $130.89 | 2020-2025 | Nemluvio |
| Dermavant Sciences, INC. | $126.56 | 2022-2024 | Vtama |
| Janssen Scientific Affairs, LLC | $120.69 | 2019 | |
| Lilly USA, LLC | $73.51 | 2022-2024 | Ebglyss, Taltz, Olumiant |
| Leo Pharma INC. | $68.03 | 2019-2023 | Adbry |
| Smith+Nephew, INC. | $66.88 | 2023-2024 | Grafix Pl, Collagenase Santyl |
| Genzyme Corporation | $43.97 | 2019-2021 | |
| Allergan, INC. | $40.46 | 2021-2022 | |
| Strata Skin Sciences, INC. | $36.67 | 2020 | |
| Merz North America, INC. | $23.00 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $21.12 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $18.42 | 2022 | |
| Genentech USA, INC. | $15.92 | 2019 | |
| Organogenesis INC. | $14.63 | 2019 | |
| Organon LLC | $4.31 | 2025 | Vtama |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Ewanowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.